.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Chubb
Novartis
UBS
Express Scripts
Citi
Fish and Richardson
Argus Health
Julphar

Generated: June 28, 2017

DrugPatentWatch Database Preview

DIUPRES-500 Drug Profile

« Back to Dashboard

Which patents cover Diupres-500, and what generic Diupres-500 alternatives are available?

Diupres-500 is a drug marketed by Merck and is included in one NDA.

The generic ingredient in DIUPRES-500 is chlorothiazide; reserpine. There are forty-one drug master file entries for this compound. Additional details are available on the chlorothiazide; reserpine profile page.

Summary for Tradename: DIUPRES-500

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list47
Clinical Trials: see list2,571
Patent Applications: see list4,983
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIUPRES-500 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
DIUPRES-500
chlorothiazide; reserpine
TABLET;ORAL011635-006Aug 26, 1987DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Baxter
Citi
Cantor Fitzgerald
Boehringer Ingelheim
US Department of Justice
Novartis
AstraZeneca
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot